Indonesian Presidential Chief of Staff: Ivermectin A Covid-19 Cure
Indonesia might get a break in its uphill struggle against Covid-19 after Indonesian officials highlighted the use of the anti-parasite drug Ivermectin as a potential treatment for the coronavirus.
Presidential Chief of Staff Moeldoko is among the leading proponents of the medication, based on its successful use in 33 countries. “According to the Front Line Covid-19 Critical Care [FLCCC] Alliance [NGO], countries like Brazil, Japan, and India have effectively used Ivermectin to overcome their Covid-19 crisis,” said the former Indonesian Armed Forces commander.
“The Covid-19 pandemic in Indonesia is currently at a critical phase, as the number of cases from the new Delta strain of the coronavirus increased. This is reflected by rising bed occupancy rates [BOR] in Covid-19 emergency hospitals around the country.”
He added that the dire situation from the pandemic entailed finding out-of-the-box solutions, among them the use of Ivermectin to treat Covid-19.
An American Journal of Therapeutics study involving 3,406 volunteers in 15 clinical groups has found that Ivermectin has a 95 percent effectiveness rate in treating Covid-19. The British Ivermectin Recommendation Development (BIRD) Group research of 24 clinical tests in 15 countries, among them Peru, Mexico, to Slovakia is just as promising, as it was shown to reduce the number of deaths among Covid-19 cases.
Data from the Indonesian Farmers Association or HKTI, which is chaired by Moeldoko, also showed that Ivermectin can reduce Covid-19 case numbers in Jakarta, Tangerang, Depok, and other cities in Indonesia by nearly 100 percent.